Guillermo de Velasco

Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome

Juan María Roldán‐Romero, María Santos, Javier Lanillos et al. · Modern Pathology · 2020 · 48 citations

Molecular Characterization, Urology, Pathway Alterations +10

Impact of the combination of durvalumab (MEDI4736) plus olaparib (AZD2281) administered prior to surgery in the molecular profile of resectable urothelial bladder cancer: NEODURVARIB Trial.

Juan Francisco Rodríguez-Moreno, Guillermo de Velasco, Inmaculada Fernández et al. · Journal of Clinical Oncology · 2020 · 43 citations

Molecular Characterization, Urology, Surgical Oncology +15

Characterization of plasma circulating small extracellular vesicles in patients with metastatic solid tumors and newly diagnosed brain metastasis

Alberto Carretero-González, Marta Hergueta‐Redondo, Sara Sánchez‐Redondo et al. · OncoImmunology · 2022 · 25 citations · Full text

Tumor Innervation, Immunology, Pathology +19

New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors

Aristotelis Bamias, Axel S. Merseburger, Yohann Loriot et al. · Journal for ImmunoTherapy of Cancer · 2023 · 21 citations · Full text

Prevalence of pathogenic germline variants in patients with metastatic renal cell carcinoma

María Santos, Javier Lanillos, Juan María Roldán‐Romero et al. · Genetics in Medicine · 2021 · 20 citations

Pathogenic Germline Variants, Urology, Genitourinary Cancer +4